TNF-α Induces Cytosolic Phospholipase A2 Expression in Human Lung Epithelial Cells via JNK1/2- and p38 MAPK-Dependent AP-1 Activation

Abstract

BackgroundCytosolic phospholipase A2 (cPLA2) plays a pivotal role in mediating agonist-induced arachidonic acid (AA) release for prostaglandin (PG) synthesis during inflammation triggered by tumor necrosis factor-α (TNF-α). However, the mechanisms underlying TNF-α-induced cPLA2 expression in human lung epithelial cells (HPAEpiCs) were not completely understood.Principal FindingsWe demonstrated that TNF-α induced cPLA2 mRNA and protein expression, promoter activity, and PGE2 secretion in HPAEpiCs. These responses induced by TNF-α were inhibited by pretreatment with the inhibitor of MEK1/2 (PD98059), p38 MAPK (SB202190), JNK1/2 (SP600125), or AP-1 (Tanshinone IIA) and transfection with siRNA of TNFR1, p42, p38, JNK2, c-Jun, c-Fos, or ATF2. We showed that TNF-α markedly stimulated p42/p44 MAPK, p38 MAPK, and JNK1/2 phosphorylation which were attenuated by their respective inhibitors. In addition, TNF-α also stimulated c-Jun and ATF2 phosphorylation which were inhibited by pretreatment with SP600125 and SB202190, respectively, but not PD98059. Furthermore, TNF-α-induced cPLA2 promoter activity was abrogated by transfection with the point-mutated AP-1 cPLA2 construct. Finally, we showed that TNF-α time-dependently induced p300/c-Fos/c-Jun/ATF2 complex formation in HPAEpiCs. On the other hand, TNF-α induced in vivo binding of c-Jun, c-Fos, ATF2, and p300 to the cPLA2 promoter in these cells. In an in vivo study, we found that TNF-α induced leukocyte count in BAL fluid of mice and cPLA2 mRNA levels in lung tissues via MAPKs and AP-1.SignificanceTaken together, these results demonstrated that TNF-α-induced cPLA2 expression was mediated through p38 MAPK- and JNK1/2-dependent p300/c-Fos/c-Jun/ATF2 complex formation in HPAEpiCs.

Inhibiting tumor necrosis factor-α signaling attenuates postoperative cognitive dysfunction in aged rats

“…c-JNK is a member of the MAPK family (25), and activation of TNF-α-mediated signaling leads to transcriptional regulation, including c-JNK phosphorylation, to stimulate transcriptional activation by activator protein 1 (AP-1) (26). In addition, activation of the p38 MAPK signaling pathway also contributes to AP-1 activation, leading to the transcriptional activation of several genes involved in inflammation, including TNF-α, IL-1β, IL-4 and IL-6 (27)(28)(29). Accordingly, the activities of the MAPK signaling pathways, including c-JNK and p38 MAPK, were investigated in the present study following the inhibition of TNF-α in the hippocampal tissue of aged rats following peripheral surgery.…”

Tumor necrosis factor-α: a key contributor to intervertebral disc degeneration

“…Stimulation of TNFR1 can also activate apoptosis-signaling kinase-1 (ASK-1), which is a member of the MEKK family and associates with TRAF2 within the complex I. ASK-1 then interacts with MAPK kinase (MEK) 4 and MEK6, which in turn activate c-Jun N-terminal kinase (JNK) and p38 MAPK [43,44]. This leads tmTNF-α α , and cIAP1/2 are then recruited to TNFR1 to form complex I.…”

Phospholipases: at the crossroads of the immune system and the pathogenesis of HIV-1 infection

“…TNF-a may also activate PI-PLCg2, resulting in NF-kB-mediated cyclooxygenase-2 expression and PGE 2 release by epithelial cells [119]. Furthermore, in these cells, TNF-a induces cPLA 2 expression to ensure a signaling network that amplifies inflammation [120].…”